Lennernäs H - Search Results

1

Variable expression of CYP and Pgp genes in the human small intestine.

Lindell M, Karlsson MO, Lennernäs H, Påhlman L, Lang MA. Lindell M, et al. Among authors: lennernas h. Eur J Clin Invest. 2003 Jun;33(6):493-9. doi: 10.1046/j.1365-2362.2003.01154.x. Eur J Clin Invest. 2003. PMID: 12795646

2

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.

Lennernäs H, Fager G. Lennernäs H, et al. Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005. Clin Pharmacokinet. 1997. PMID: 9160173 Review.

3

Human jejunal effective permeability and its correlation with preclinical drug absorption models.

Lennernäs H. Lennernäs H. J Pharm Pharmacol. 1997 Jul;49(7):627-38. doi: 10.1111/j.2042-7158.1997.tb06084.x. J Pharm Pharmacol. 1997. PMID: 9255703 Review.

4

Human intestinal permeability.

Lennernäs H. Lennernäs H. J Pharm Sci. 1998 Apr;87(4):403-10. doi: 10.1021/js970332a. J Pharm Sci. 1998. PMID: 9548891 Review.

5

Absorption of L-DOPA from the proximal small intestine studied in the rhesus monkey by positron emission tomography.

Nilsson D, Lennernäs H, Fasth KJ, Sundin A, Tedroff J, Aquilonius SM, Hartvig P, Långström B. Nilsson D, et al. Among authors: lennernas h. Eur J Pharm Sci. 1999 Feb;7(3):185-9. doi: 10.1016/s0928-0987(98)00018-9. Eur J Pharm Sci. 1999. PMID: 9845804

6

The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans.

Sandström R, Knutson TW, Knutson L, Jansson B, Lennernäs H. Sandström R, et al. Among authors: lennernas h. Br J Clin Pharmacol. 1999 Aug;48(2):180-9. doi: 10.1046/j.1365-2125.1999.00999.x. Br J Clin Pharmacol. 1999. PMID: 10417494 Free PMC article.

7

In vitro metabolism of opioid tetrapeptide agonists in various tissues and subcellular fractions from rats.

Krondahl E, von Euler-Chelpin H, Orzechowski A, Ekström G, Lennernäs H. Krondahl E, et al. Among authors: lennernas h. Peptides. 2001 Apr;22(4):613-21. doi: 10.1016/s0196-9781(01)00328-x. Peptides. 2001. PMID: 11311732

8

CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies.

Engman HA, Lennernäs H, Taipalensuu J, Otter C, Leidvik B, Artursson P. Engman HA, et al. Among authors: lennernas h. J Pharm Sci. 2001 Nov;90(11):1736-51. doi: 10.1002/jps.1123. J Pharm Sci. 2001. PMID: 11745731

9

Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson's disease on individual drug combinations.

Nyholm D, Lennernäs H, Gomes-Trolin C, Aquilonius SM. Nyholm D, et al. Among authors: lennernas h. Clin Neuropharmacol. 2002 Mar-Apr;25(2):89-96. doi: 10.1097/00002826-200203000-00006. Clin Neuropharmacol. 2002. PMID: 11981235

10

Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs.

Sun D, Lennernas H, Welage LS, Barnett JL, Landowski CP, Foster D, Fleisher D, Lee KD, Amidon GL. Sun D, et al. Among authors: lennernas h. Pharm Res. 2002 Oct;19(10):1400-16. doi: 10.1023/a:1020483911355. Pharm Res. 2002. PMID: 12425456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results